OCUL

Ocular Therapeutix, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$8.49

Market Cap

$1.85B

Beta

0.95

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-18.47%

EPS Growth (YoY)-14.29%

Revenue CAGR 3Y+0.30%

P/E Ratio0.0

PEG Ratio—

FCF Yield-11.74%

Debt / Equity0.12

Interest Coverage-22.8x

No credit card required

Already have an account? Sign in to view the full analysis for OCUL.